Announcements
14 July 2025
Meet Us Virtually at the 1st International Online Conference on Hematology, 28–30 October 2026
6 August 2026
Welcoming New Editorial Board Members Who Joined Cancers in July 2026
6 August 2026
Meet Us at the ESMO Congress 2026, 23–27 October 2026, Madrid, Spain
5 August 2026
Cancers | Childhood Cancer Awareness Month
August is designated as Childhood Cancer Awareness Month, a time dedicated to raising global awareness and advancing research and development efforts in pediatric oncology. We would like to take this opportunity to extend our sincere appreciation to all researchers dedicated to fighting this disease. In light of this, we are pleased to highlight a selection of high-quality, innovative research in childhood cancer published in Cancers (ISSN 2072-6694). We hope these publications offer valuable insights for your ongoing work. Please find the list of featured papers below.
“Long-Term Survival and Risk of Second Malignant Neoplasms Among Childhood Cancer Patients in 16 Provinces of Spain”
by Jaume Galceran, Alberto Ameijide, Noura Jeghalef, Antonia Sánchez, Marcela Guevara, Jàmnica Bigorra, Pilar Gutiérrez, An L. D. Boone, Montserrat Garrido, Xitama Álvarez et al.
Cancers 2026, 18(12), 1991; https://doi.org/10.3390/cancers18121991
“DNA Methylation of Pharmacologic and Leukemia-Related Genes Predicts Clinical Outcomes in Pediatric Acute Myeloid Leukemia”
by Naifah Alshameri, Francisco Marchi, Xueyuan Cao, Jeffrey E. Rubnitz, Raul C. Ribeiro, Soheil Meshinchi, Stanley B. Pounds and Jatinder K. Lamba
Cancers 2026, 18(15), 2467; https://doi.org/10.3390/cancers18152467
“Benefits of Physiotherapy Interventions in Survivors of Childhood Cancer: A Systematic Review with Meta-Analysis”
by Lucía Ortiz-Comino, Tania María Abril-Mera, Miguel Ángel Fernández-Gualda, Mario Lozano-Lozano, Fahed Herbawi and Carolina Fernández-Lao
Cancers 2026, 18(5), 855; https://doi.org/10.3390/cancers18050855
“Structured and Unstructured Physical Activity, Screen Time and Quality of Life in Childhood Cancer Survivors”
by Lauren Ha, Darcy Singleton, Claire E. Wakefield, Richard J. Cohn, David Simar and Christina Signorelli
Cancers 2026, 18(5), 752; https://doi.org/10.3390/cancers18050752
“Subsequent Primary Neoplasms and Mortality Among Survivors of Childhood Cancer in Alberta, Canada”
by King Wa Tam, Tona M. Pitt, Kathleen Reynolds, Maria Spavor, Tony H. Truong, Jennifer Giles, Gregory M. T. Guilcher, Natalie Logie, Iqra Rahamatullah, Fiona Schulte et al.
Cancers 2026, 18(4), 694; https://doi.org/10.3390/cancers18040694
“External Validation and Feedback-Driven Improvement of the Diagnostic Model for Pediatric Cervical Lymphadenopathy”
by Rachel M. A. Vreugdenhil, Tammo P. A. Beishuizen, C. Michel Zwaan, Auke Beishuizen and Eline A. M. Zijtregtop
Cancers 2026, 18(15), 2407; https://doi.org/10.3390/cancers18152407
“Prophylactic PEG-rhG-CSF Reduces Febrile Neutropenia in Pediatric Hematological Malignancies Compared with Daily rhG-CSF”
by Xiao Zhang, Yang Fu, Hongsheng Wang, Xiaohua Zhu, Yi Yu, Ping Cao, Chen Shen and Xiaowen Zhai
Cancers 2026, 18(14), 2214; https://doi.org/10.3390/cancers18142214
“Prognostic Value of Pre-Treatment Systemic Inflammatory Markers in Pediatric Unilateral Wilms Tumor”
by Hadeel Halalsheh, Lana Amer, Mohammad Alzoubi, Noor F. Al-Assaf, Adam Diab, Nada Odeh and Iyad Sultan
Cancers 2026, 18(13), 2179; https://doi.org/10.3390/cancers18132179
“Strategies to Improve Sensitivity to Radiotherapy in Pediatric Solid Tumors”
by Maryam G. Shaikh, Morgan L. Brown, Jamie M. Aye and Elizabeth A. Beierle
Cancers 2026, 18(13), 2103; https://doi.org/10.3390/cancers18132103
“Clinical Characteristics and Survival Outcomes in a Cohort of Pediatric Rhabdomyosarcoma Patients: The Impact of Risk-Adapted Therapy”
by Yanhua Li, Yangyang Jiao, Xuelian Liao, Jingbo Shao, Ting Zhang, Can Huang, Jingwei Yang and Shayi Jiang
Cancers 2026, 18(11), 1848; https://doi.org/10.3390/cancers18111848
|
“Current Research in Pediatric Hematological Oncology” |
“Targeted Therapies for Pediatric Nervous System Tumors” |
 |
“Pediatric Cancers” Edited by Saurabh Agarwal and Jianhua Yang ISBN 978-3-0365-9024-0 (Hardback) ISBN 978-3-0365-9025-7 (PDF) https://doi.org/10.3390/books978-3-0365-9025-7 This is a reprint of the Special Issue “Pediatric Cancers” that was published in Cancers. |
5 August 2026
MDPI INSIGHTS: The CEO’s Letter #37 – Canada Summit, Sciforum Relaunch, 30 Years of Impactful Research & ISPRS 2026
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Reflections from the MDPI Canada Summit 2026 in Toronto (9–10 July)
As part of this year’s MDPI Summit events, we were delighted to host Editors-in-Chief (EiCs) and Editorial Board Members (EBMs) in Toronto for the MDPI Canada Summit 2026 this July.
Across the two days, we presented on topics including research integrity, editorial leadership, artificial intelligence, peer review, and the evolving role of the EiC. More importantly, the Summit created space for feedback and conversations with the academic community: these engagements continue play and important role in shaping how MDPI develops its journals and services.
Why Canada?
Canada has become one of the world’s leading Open Access (OA) nations. In 2025, 68% of Canadian research publications were published OA, with more than 73,000 OA articles produced during the year. Over the past five years alone, Canadian researchers have published more than 526,000 scholarly articles, showing both the scale and quality of Canadian research.
MDPI Toronto Office
“Canada has become one of the world’s leading Open Access nations”
Since opening in 2019, our Toronto office has grown to more than 85 colleagues supporting editorial operations, research integrity, marketing, societies, conferences, indexing, author services, and many other functions across North America. It was great to spend time with the team, see first-hand the energy and enthusiasm they bring to their work, and recognize the significant role they play in building relationships with the Canadian research community and delivering events such as this Summit.
MDPI and Canada
Today, Canada is an important part of the MDPI community:
- More than 53,800 articles from Canadian institutions published with MDPI since 1996
- More than 5,800 MDPI publications from Canadian researchers in 2025
- Nearly 1,900 Canadian Editorial Board Members, including 24 Editors-in-Chief; 49 Section Editors-in-Chief
- More than 30 Institutional Open Access Partnerships (IOAP) with universities across Canada
“The academic community is at the center of everything we do”
These numbers reflect the long-term partnerships with researchers, reviewers, editors, and institutions who continue to place their trust in MDPI.
Summit Program
Throughout the Summit, we presented and discussed topics against the following agenda:
- MDPI at 30: Introduction, Reflections and the Road Ahead – Stefan Tochev (CEO)
- Engagement with Academic Community and Society Partnerships – Karen Irwin (Associate Editorial Engagement Manager) and Carla Aloè (Head of Societies and Acquisition)
- Latest Developments in the Editorial Process – Summer Huggard (Operations Manager)
- Research Integrity and Publication Ethics – Renato Merki (Research Integrity Specialist)
- AI and Technology in Publishing – Dr. Barnaby Crook (Regional Engagement Editor)
- Panel Discussion – Bob Vrooman (Head of Business Development / Operations Manager, USA), Summer Huggard, Renato Merki, and myself
These presentations reinforce something we often say at MDPI: The academic community is at the center of everything we do. Each session concluded with a Q&A, allowing for discussions throughout the Summit to engage directly with our EiCs and EBMs.
Further Reading
I also had the opportunity to be interviewed by University Affairs about the evolving landscape of scholarly publishing, Open Access, and the importance of engaging with the research community. If you’re interested, you can read the interview in:
- English: University Affairs – MDPI Toronto Summit 2026: Bringing Together Leaders to Shape the Future of Scholarly Publishing
- Français: Affaires universitaires – Sommet MDPI de Toronto 2026
Thank You
As OA continues to grow around the world, events such as the MDPI Canada Summit remind us of the importance of meeting with our academic community in person. Listening to feedback, exchanging ideas, and building relationships are essential to ensuring that MDPI continues to evolve alongside the researchers, editors, reviewers, and institutions we serve.
Impactful Research
Five Journals, Five Different Stories of Success
Each year, the release of the Journal Citation Reports (JCR) provides an opportunity to look at the progress of our journal portfolio and, more importantly, the achievements of the research communities behind it.
A recent MDPI Blog article from Tommy Lax (Content Specialist, MDPI) highlights five journals whose 2025 Journal Impact Factor results show that success can take many forms – from achieving a first Impact Factor, to steady long-term growth, to leadership within highly competitive disciplines.
The featured journals include:
- Machine Learning & Knowledge Extraction (MAKE) – Among the 330 MDPI journals which received an Impact Factor in 2025, MAKE (ISSN 2504-4990) holds the accolade of having the highest rating of 8.4. The journal, which provides an advanced forum for the study of machine learning and its applications, is placed in Q1 for three subject categories: Computer science, artificial intelligence; Computer science, interdisciplinary applications; and Engineering, electrical & electronic.
- Antioxidants – Continuing its strong position across multiple scientific disciplines, Antioxidants (ISSN 2076-3921) was awarded an exceptional Impact Factor of 8.2. In addition, the journal was placed in Q1 in three subject categories: Biochemistry & molecular biology; Chemistry, medicinal; and Food science & technology.
- Biomass – This year, Biomass (ISSN 2673-8783) was recognized in the JCR for the first time, with a strong debut Impact Factor of 6.7. What makes this achievement even more impressive is the journal’s placement in Q1 of the category Engineering, chemical.
- Analytica – Remaining with the theme of growth, Analytica (ISSN 2673-4532), which provides an advanced forum for all aspects of fundamental and applied analytical chemistry, recorded one of the largest year-on-year increases in Journal Impact Factor, with a 7.4 – an astounding 3.8-point increase from its 2024 rating of 3.6.
- Batteries – Indexed in SCIE, Batteries (ISSN 2313-0105) received an updated Impact Factor of 6.3 this year, representing an increase of 1.5 versus last year, demonstrating consistent growth and increasing visibility over several years.
While citation metrics provide one perspective on journal performance, they tell only part of the story. Every milestone reflects the dedication of Editors-in-Chief, Editorial Board Members, reviewers, authors, and colleagues across MDPI who work together to uphold rigorous editorial standards and support high-quality research.
As a signatory of the Declaration on Research Assessment (DORA), MDPI supports a balanced approach to research evaluation. Journal-level metrics should be viewed alongside article-level indicators and the broader scientific and societal impact of published research.
Thank you to everyone whose commitment continues to strengthen our journals and advance Open Access across the global research community.
Inside MDPI
Building Better Tools for the Research Community: The Relaunch of Sciforum
Innovation at MDPI extends beyond journals. Over the past decade, we have continued to invest in products that support researchers, conference organizers, editors, reviewers, and institutions throughout the research lifecycle. As part of this ongoing investment, our Product and Engineering teams have been modernizing several of MDPI’s digital platforms. One important milestone in that journey is the relaunch of Sciforum, our conference management platform.
Read More: Sciforum Relaunch: Empowering Science through Seamless Event Management
Rather than simply updating an existing system, our product and engineering teams have rebuilt Sciforum, using a modern architecture designed to improve the user experience, support future growth, and continue to strengthen our position in the conference management market.
“Scalable technology is essential to delivering a high-quality experience”
Why We Rebuilt Sciforum
Technology must continue evolving alongside the needs of our users. The previous platform had served MDPI well for many years but had become difficult to extend and maintain. The new platform introduces a modular architecture that enables faster development, more flexibility, and a scalable foundation for future work.
Major improvements include:
- Simplified submission workflows
- Role-based dashboards
- A modern website builder
- Flexible pricing options
- Permanent data hosting
- A scalable architecture for future development
Supporting Our Conference Community
Sciforum is more than a software platform: it supports researchers, conference organizers, reviewers, speakers, and attendees by helping them organize, participate in, and share scientific meetings more efficiently. As MDPI continues to expand its conference activities worldwide, investing in modern, scalable technology is essential to delivering a high-quality experience for both our external partners and our internal teams.
Looking Ahead
The relaunch represents the beginning Sciforum’s next chapter. Planned improvements include: the Program Builder, Communication Hub, expanded payment options, Zoom integration, and a mobile application. These will continue to enhance the platform over the coming months.
Coming Together for Science
Highlights from ISPRS Congress 2026 – Toronto, Canada
In early July, I had the pleasure of attending the XXV ISPRS Congress in Toronto, one of the world’s leading gatherings for the geospatial and remote sensing research community. It was a great opportunity to meet researchers, editors, society leaders, and collaborators, while gaining insights into some of the latest developments in geospatial science and technology.
Over several days, I had the privilege of presenting the Jack Dangermond Award; speaking about MDPI’s approach to AI in publishing and our 30-year journey in Open Access publishing; participating in Editorial Board meetings; and engaging with members of the ISPRS community.
Below is a summary of these activities:
Celebrating excellence in research
One of the highlights of the week was presenting the Jack Dangermond Award for the best paper published in the ISPRS International Journal of Geo-Information (IJGI). Sponsored by MDPI and ESRI, the award recognizes an outstanding paper published over a four-year period and includes an ISPRS certificate together with a USD 10,000 prize.
Awards such as these remind us that journals are much more than publication platforms: they celebrate research that advances knowledge, inspires future work, and delivers meaningful impact for both science and society.
Presentations at ISPRS
I also had the pleasure to give two presentations during the congress:
1. The AI Revolution in Publishing: Challenges, Innovations, and MDPI’s Vision
The development of AI continues to transform scholarly publishing. During this session, I shared how MDPI is integrating AI responsibly, not to replace editorial judgement or peer review, but to support our staff by improving efficiency while maintaining scientific quality and research integrity.
2. MDPI: 30 Years of Open Access Publishing
I also had the opportunity to share MDP’s 30-year journey from a small publishing initiative to becoming a global Open Access publisher serving millions of researchers worldwide. As part of this session, my colleague Carla Aloè (Head of Societies and Acquisitions) introduced the ISPRS International Journal of Geo-Information (IJGI), sharing its development and contribution to the geospatial research community.
Meeting with Our Editorial Boards
Another rewarding aspect of the congress was meeting with the Editorial Boards of two of our journals:
- Remote Sensing
- ISPRS International Journal of Geo-Information
These discussions went beyond journal metrics. We heard ideas about editorial quality and emerging research areas, and we discussed reviewer engagement, diversity within editorial boards, and how journals can continue serving their communities for the future. These conversations are a great way to connect directly to the scientists who help shape our journals.
“One of our core missions has always been to make high-quality research openly accessible”
Partnerships matter
Scientific publishing is built on collaboration. Throughout the congress, our team welcomed researchers to the MDPI booth, met with authors and editors, and discussed opportunities for collaboration across our journals and society partnerships.
Special thanks to our MDPI colleagues who were present throughout the ISPRS congress supporting our Editorial Board meetings and the MDPI booth: Andy Tran, Carla Aloè, Carlo Cunanan, Diana Ribeiro Tosato, and Elena Duan.
Thank you to ISPRS for organizing this congress, to the researchers who shared their work, to our Editorial Board members, and to MDPI colleagues whose dedication continues to shape the journals and communities we support.
Closing Thoughts
Insights Into 30 Years of Impactful MDPI Research
As we celebrate 30 years of MDPI, it’s worth reflecting on the impact that the research we publish has on society. One of our core missions has always been to make high-quality research openly accessible so that it can inform new discoveries, public policy, education and innovation around the world.
A recent article on the MDPI Blog highlights several examples of MDPI publications that have gone beyond academic citations to help inform governments, international organizations and public policy discussions.
Research Creating Real-World Impact
The MDPI blog article features research that has contributed to topics including:
- protecting the Amazon rainforest through satellite mapping
- understanding climate change and urban heat inequality
- encouraging more young women to pursue STEM careers
- tackling obesity through healthier food environments
- shaping sustainable urban planning through the “15-minute city” concept
These examples remind us that publishing research is not only about producing articles: it is about helping knowledge reach the people who can use it to improve lives and address global challenges.
Thirty Years of Open Access
MDPI’s 30th Anniversary is also an opportunity to recognize the collective contribution of everyone across MDPI. Every manuscript processed, every review coordinated, every system developed, every conference organized, every partnership established and every article published contributes to a much larger purpose: helping scientific knowledge move further and faster.
You can explore the full article here: 30 Years of Impactful MDPI Research
You can also visit our 30th Anniversary page to learn more about MDPI’s journey over the past three decades.
Chief Executive Officer
MDPI AG
29 July 2026
Topics Webinar | Kinases, Cancer, Drugs and Artificial Intelligence, 10 August 2026
Today, we turn our focus to a field that has become central to modern oncology: the study and therapeutic targeting of protein kinases. Over the past two decades, kinases have emerged as one of the most clinically successful classes of drug targets in cancer. These enzymes act as critical molecular switches, governing a vast network of signaling pathways that control cell proliferation, survival, and metabolism. When dysregulated—whether through mutation, overexpression, or chromosomal translocation—kinases drive the hallmark behaviors of malignancy.
It is no exaggeration to say that the discovery of kinase inhibitors has transformed the therapeutic landscape. From the groundbreaking success of imatinib in chronic myeloid leukemia to the latest generation of highly selective ATP-competitive and allosteric inhibitors, we have seen how a deep understanding of kinase biology can translate into life-saving drugs. However, we are also acutely aware of the persistent challenges: acquired resistance, off-target toxicity, and the daunting complexity of kinase signaling networks. The question is no longer simply which kinase to target, but how to target it more intelligently, more selectively, and for the right patient at the right time.
This is where artificial intelligence enters the picture, and while much of our conversation will be anchored in kinase biology, we will explore how AI is beginning to accelerate drug discovery—from structure prediction to virtual screening. Yet let us be clear: biology remains the foundation. Our goal today is to ask how these powerful computational tools can help us navigate the complexity of the kinome and ultimately improve patient outcomes.
Date: 10 August 2026 at 4:00 p.m. CEST | 10:00 a.m. EDT
Webinar ID: 889 3819 0599
Register now for free!
Program:
|
Speaker/Presentation |
Time in CEST |
Time in EDT |
|
Dr. Jonas Cicenas Chair Introduction |
4:00–4:10 p.m. |
10:00–10:10 a.m. |
|
Dr. Jonas Cicenas AI and Machine Learning in Kinase Inhibitor Development |
4:10–4:30 p.m. |
10:10–10:30 a.m. |
|
Prof. Dr. Lee M. Graves Applying Affinity Proteomics to Profile Kinome Dynamics and Inhibitor Specificity |
4:30–4:50 p.m. |
10:30–10:50 a.m. |
|
Dr. Eglė Žalytė Targeting Kinases in Gynecological Cancers: From Molecular Pathways to Clinical Practice |
4:50–5:10 p.m. |
10:50–11:10 a.m. |
|
Q&A Session |
5:10–5:25 p.m. |
11:10–11:25 a.m. |
|
Dr. Jonas Cicenas Closing of Webinar |
5:25–5:30 p.m. |
11:25–11:30 a.m. |
After registering, you will receive a confirmation email containing information on how to join the webinar.
Registrations with academic institutional email addresses will be prioritized.
If you are unable to attend, please register anyway, and we will let you know when the recording is available to watch.
Webinar Chair and Keynote Speakers:
- Dr. Jonas Cicenas, 1 Faculty of Informatics, Engineering and Technologies, Kauno Kolegija Higher Education Institution, Lithuania; 2 SMK College of Applied Sciences, Kalvarijų, Lithuania; 3 UAB CDKjc, Kukučių, Lithuania;
- Prof. Dr. Lee M. Graves, Department of Pharmacology, University of North Carolina at Chapel Hill, NC;
- Dr. Eglė Žalytė, Institute of Biosciences, Life Sciences Center, Vilnius University, Lithuania.
Relevant Topics:
“Kinases in Cancer and Other Diseases, 2nd Edition”
Topic Editors: Dr. Jonas Cicenas and Dr. Anna M. Czarnecka
Abstract submission deadline: 31 July 2026
Manuscript submission deadline: 31 August 2026
“Kinases and GTPases in Cancer: The Role of Mutations and sRNAs”
Topic Editors: Dr. Jonas Cicenas and Prof. Dr. Lee M. Graves
Abstract submission deadline: 31 October 2027
Manuscript submission deadline: 31 December 2027
For more information about this webinar, please visit the following website:
https://sciforum.net/event/TOPICS-51.
If you have any questions about this event, please contact journal.webinar@mdpi.com.
Topics Webinar Secretariat
28 July 2026
Meet Us at the 85th Annual Meeting of the Japanese Cancer Association, 24–26 September 2026, Kyoto, Japan
27 July 2026
Cancers | Feature Papers from the Second Half of 2025 in the “Cancer Metastasis” Section
23 July 2026
Cancers | Highly Cited Papers Published in 2024–2025 in Web of Science (II)
22 July 2026
Cancers | Feature Papers from the Second Half of 2025 in the “Clinical Research in Cancer” Section
